CIK 1012622
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q3. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Health Care Providers & Services | 78.79% | 3 |
| Pharmaceuticals & Biotechnology | 16.94% | 6 |
| Unclassified | 3.16% | 4 |
| Hotels, Restaurants & Leisure | 0.66% | 1 |
| Software & IT Services | 0.25% | 1 |
| Automobiles & Components | 0.15% | 1 |
| Commercial Services & Supplies | 0.05% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | WGS | GeneDx Holdings Corp. | Health Care | 75.40% |
| 2 | ARDX | ARDELYX, INC. | Health Care | 7.15% |
| 3 | BHVN | Biohaven Ltd. | Health Care | 5.71% |
| 4 | QDEL | QuidelOrtho Corp | Health Care | 2.21% |
| 5 | FORA | FORIAN INC | Unclassified | 1.90% |
| 6 | PSNL | Personalis, Inc. | Health Care | 1.77% |
| 7 | TDOC | Teladoc Health, Inc. | Health Care | 1.63% |
| 8 | TSHA | Taysha Gene Therapies, Inc. | Health Care | 0.96% |
| 9 | CAVA | CAVA GROUP, INC. | Consumer Discretionary | 0.66% |
| 10 | EWTX | Edgewise Therapeutics, Inc. | Health Care | 0.62% |
13/17 names classified · sector 96.8% of weight · industry 96.8% · mkt cap 96.8%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 96.8% of the book is sector-classified (unclassified names shown, never dropped).
Only 1% of book weight classified — the grid is NOT representative of the whole book.
Classified: 1.3% of book weight (4/17 names) · unclassified 98.7%: WGS, ARDX, BHVN, QDEL, FORA, PSNL, TDOC, TSHA, EWTX, +3 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | WGSGENEDX HOLDINGS CORP | 884,654 | $115M | 75.4% | HOLD |
| 2 | ARDXARDELYX INC | 1,872,624 | $11M | 7.2% | ADD 25% |
| 3 | BHVNBIOHAVEN LTD | 772,181 | $9M | 5.7% | ADD 4% |
| 4 | QDELQUIDELORTHO CORP | 118,291 | $3M | 2.2% | HOLD |
| 5 | FORAFORIAN INC | 1,366,107 | $3M | 1.9% | HOLD |
| 6 | PSNLPERSONALIS INC | 339,343 | $3M | 1.8% | ADD 48% |
| 7 | TDOCTELADOC HEALTH INC | 354,338 | $2M | 1.6% | TRIM −50% |
| 8 | TSHATAYSHA GENE THERAPIES INC | 265,000 | $1M | 1.0% | NEW |
| 9 | CAVACAVA GROUP INC | 17,100 | $1M | 0.7% | HOLD |
| 10 | EWTXEDGEWISE THERAPEUTICS INC | 38,343 | $951,482 | 0.6% | NEW |
| 11 | DAY ONE BIOPHARMACEUTICALS I | 100,000 | $932,000 | 0.6% | NEW |
| 12 | ARKGARK ETF TR | 19,500 | $564,915 | 0.4% | NEW |
| 13 | SGMOQSANGAMO THERAPEUTICS INC | 1,035,742 | $435,012 | 0.3% | ADD 3% |
| 14 | BIIBBIOGEN INC | 2,412 | $424,488 | 0.3% | HOLD |
| 15 | TEMTEMPUS AI INC | 6,507 | $384,238 | 0.3% | NEW |
| 16 | TSLATESLA INC | 500 | $224,860 | 0.1% | HOLD |
| 17 | HTZHERTZ GLOBAL HLDGS INC | 15,000 | $77,100 | 0.1% | NEW |
Where this firm's principals came from and which firms its alumni went on to found.
